טוען...
Targeting liver cancer stem cells for the treatment of hepatocellular carcinoma
Liver cancer is one of the most common malignant tumors and prognosis remains poor. It has been increasingly recognized that liver cancer stem cells (LCSCs) are responsible for the carcinogenesis, recurrence, metastasis and chemoresistance of hepatocellular carcinoma (HCC). Targeting LCSCs is promis...
שמור ב:
| הוצא לאור ב: | Therap Adv Gastroenterol |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
SAGE Publications
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6348509/ https://ncbi.nlm.nih.gov/pubmed/30719075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756284818821560 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|